Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Provide better absorption of essential nutrients
The milligram figure is route-specific, not a stronger dose than the injection
Most clinicians recommend B12 injections every 1 to 4 weeks for deficiency treatment and once a month for maintenance after deficiency is corrected
| Agent | FDA Approval | Mean Weight Loss (RCT) | Route | |---|---|---|---| | Semaglutide 2.4 mg (Wegovy) | Yes (2021) | 14.9% at 68 weeks (STEP-1, N=1,961) [9] | Subcutaneous weekly | | Tirzepatide 15 mg (Zepbound) | Yes (2023) | 20.9% at 72 weeks (SURMOUNT-1, N=2,539) [11] | Subcutaneous weekly | | AOD-9604 1 mg oral | No | ~2.8 kg at 12 weeks (Phase IIb, N=300 approx.) [1] | Oral (not currently compounded) | The weight-loss magnitude from the single Phase IIb AOD-9604 trial is substantially smaller than what STEP-1 (semaglutide) and SURMOUNT-1 (tirzepatide) demonstrated in larger, longer trials
US$ 22.94
US$ 21.80
US$ 29.46
US$ 29.97
US$ 28.13
US$ 23.24
US$ 29.18
US$ 27.41
